KLK3 and metastatic prostate carcinoma: A markedly elevated prostate-specific antigen (130 μg/L) alongside MRI findings of a prostate imaging reporting and data system, category 5 (PI-RADS 5) lesion in the prostate, pelvic nodal disease, and lytic bony metastases suggested a radiological diagnosis of metastatic prostate cancer.